HUB-101

N/A

Report date: 2025/04/07 14:32:47

Base Information

Drug NameHUB-101
Drug Alias NameHUB-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionInward rectifier potassium channel 13 gene transference
TargetsInward rectifier potassium channel 13
Therapy Area/IndicationsSnowflake Vitreoretinal DegenerationLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHubble Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesHubble Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsSnowflake Vitreoretinal DegenerationLeber Congenital Amaurosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A